P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL
Introduction and Objectives: Hepatitis caused by the C virus (HCV) is a public health problem whose greatest challenge is access to diagnosis and treatment. The population deprived of liberty is considered a priority for approaches involving the disease. This study aimed to identify the prevalence o...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268123000297 |
| _version_ | 1797862199402692608 |
|---|---|
| author | Eduardo Emerim Viviane De Lima Cezar Elenita Majaro Pinto Ferreira Ana Francisca Perinazzo Fontoura Daniel Conte Herter Roslaine Ifran Amaral João Nagildo Rafael De Oliveira Nogueira Cibele Dresch Pauline Soares Ferrugem |
| author_facet | Eduardo Emerim Viviane De Lima Cezar Elenita Majaro Pinto Ferreira Ana Francisca Perinazzo Fontoura Daniel Conte Herter Roslaine Ifran Amaral João Nagildo Rafael De Oliveira Nogueira Cibele Dresch Pauline Soares Ferrugem |
| author_sort | Eduardo Emerim |
| collection | DOAJ |
| description | Introduction and Objectives: Hepatitis caused by the C virus (HCV) is a public health problem whose greatest challenge is access to diagnosis and treatment. The population deprived of liberty is considered a priority for approaches involving the disease. This study aimed to identify the prevalence of HCV among patients tested in prisons in Porto Alegre, Brazil and describe the diagnosed profile of the patients. Materials and Methods: A cross-sectional study with a quantitative approach. Through the “test and treat” project, rapid testing for HCV and the treatment of diagnosed cases were carried out, providing specific pharmacotherapy, without face-to-face specialist medical consult, within 30 days in 5 prisons in Porto Alegre. Results: 1272 tests were performed with a prevalence of 2.04% of HCV (table 1).The ''test and treat'' also welcomed patients diagnosed at the entrance door of prisons providing treatment for the disease, totaling 44 patients diagnosed in these prisons. With the exception of 3 patients with non-reactive viral load, 24.4% of patients have already completed treatment, 36.6% of patients are currently undergoing treatment, 22% are awaiting test results or a change of antiretroviral regimen for HIV and 17.1 % went free from prison. As for the profile of patients, 81.8% are male. The age group with the highest prevalence of patients is 41 to 50 years old (33.3%). Regarding race/color, 41.9% of patients are black and 58.1% are white. Regarding drug use, 50% of patients reported using or had used injectable, inhaled substances and/or crack. The patient's APRI score was 0.6 (F0-F1) and FIB-4 was 1.28 (F0-F1). Conclusions: This is an innovative action for the Population Deprived of Liberty, as it is the first time that patients with HCV have been treated in municipal prisons because of the particularities of the prison system. Funding: This work was supported by an unrestricted grant provided by Gilead Sciences Brazil. |
| first_indexed | 2024-04-09T22:16:28Z |
| format | Article |
| id | doaj.art-ae1b5f703d764e66901a3b20fd380d24 |
| institution | Directory Open Access Journal |
| issn | 1665-2681 |
| language | English |
| last_indexed | 2024-04-09T22:16:28Z |
| publishDate | 2023-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Annals of Hepatology |
| spelling | doaj.art-ae1b5f703d764e66901a3b20fd380d242023-03-23T04:33:57ZengElsevierAnnals of Hepatology1665-26812023-03-0128100925P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZILEduardo Emerim0Viviane De Lima Cezar1Elenita Majaro Pinto Ferreira2Ana Francisca Perinazzo Fontoura3Daniel Conte Herter4Roslaine Ifran Amaral5João Nagildo6Rafael De Oliveira Nogueira7Cibele Dresch8Pauline Soares Ferrugem9Tuberculosis Care Coordination, STI, HIV-Aids and Viral Hepatitis, Municipal Health Secretariat, Porto Alegre, BrazilTuberculosis Care Coordination, STI, HIV-Aids and Viral Hepatitis, Municipal Health Secretariat, Porto Alegre, BrazilPrison Health Unit CPPA, Superintendence of Penitentiary Services, Porto Alegre, BrazilPrison Health Unit PFMP/PEPOA, Vila Nova Hospital Association, Porto Alegre, BrazilPrison Health Unit PFMP/PEPOA, Vila Nova Hospital Association, Porto Alegre, BrazilPrison Health Unit IPF, Superintendence of Penitentiary Services, Porto Alegre, BrazilTuberculosis Care Coordination, STI, HIV-Aids and Viral Hepatitis, Municipal Health Secretariat, Porto Alegre, BrazilSpecialized Assistance Service Santa Marta, Municipal Health Secretariat, Porto Alegre, BrazilSpecialized Assistance Service Santa Marta, Municipal Health Secretariat, Porto Alegre, BrazilTuberculosis Care Coordination, STI, HIV-Aids and Viral Hepatitis, Municipal Health Secretariat, Porto Alegre, BrazilIntroduction and Objectives: Hepatitis caused by the C virus (HCV) is a public health problem whose greatest challenge is access to diagnosis and treatment. The population deprived of liberty is considered a priority for approaches involving the disease. This study aimed to identify the prevalence of HCV among patients tested in prisons in Porto Alegre, Brazil and describe the diagnosed profile of the patients. Materials and Methods: A cross-sectional study with a quantitative approach. Through the “test and treat” project, rapid testing for HCV and the treatment of diagnosed cases were carried out, providing specific pharmacotherapy, without face-to-face specialist medical consult, within 30 days in 5 prisons in Porto Alegre. Results: 1272 tests were performed with a prevalence of 2.04% of HCV (table 1).The ''test and treat'' also welcomed patients diagnosed at the entrance door of prisons providing treatment for the disease, totaling 44 patients diagnosed in these prisons. With the exception of 3 patients with non-reactive viral load, 24.4% of patients have already completed treatment, 36.6% of patients are currently undergoing treatment, 22% are awaiting test results or a change of antiretroviral regimen for HIV and 17.1 % went free from prison. As for the profile of patients, 81.8% are male. The age group with the highest prevalence of patients is 41 to 50 years old (33.3%). Regarding race/color, 41.9% of patients are black and 58.1% are white. Regarding drug use, 50% of patients reported using or had used injectable, inhaled substances and/or crack. The patient's APRI score was 0.6 (F0-F1) and FIB-4 was 1.28 (F0-F1). Conclusions: This is an innovative action for the Population Deprived of Liberty, as it is the first time that patients with HCV have been treated in municipal prisons because of the particularities of the prison system. Funding: This work was supported by an unrestricted grant provided by Gilead Sciences Brazil.http://www.sciencedirect.com/science/article/pii/S1665268123000297 |
| spellingShingle | Eduardo Emerim Viviane De Lima Cezar Elenita Majaro Pinto Ferreira Ana Francisca Perinazzo Fontoura Daniel Conte Herter Roslaine Ifran Amaral João Nagildo Rafael De Oliveira Nogueira Cibele Dresch Pauline Soares Ferrugem P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL Annals of Hepatology |
| title | P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL |
| title_full | P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL |
| title_fullStr | P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL |
| title_full_unstemmed | P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL |
| title_short | P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL |
| title_sort | p 23 test and treat profile of patients diagnosed with hepatitis c in the prison system of porto alegre brazil |
| url | http://www.sciencedirect.com/science/article/pii/S1665268123000297 |
| work_keys_str_mv | AT eduardoemerim p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT vivianedelimacezar p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT elenitamajaropintoferreira p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT anafranciscaperinazzofontoura p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT danielconteherter p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT roslaineifranamaral p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT joaonagildo p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT rafaeldeoliveiranogueira p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT cibeledresch p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil AT paulinesoaresferrugem p23testandtreatprofileofpatientsdiagnosedwithhepatitiscintheprisonsystemofportoalegrebrazil |